TY - JOUR
T1 - Symptoms as an Indicator of Microbial Keratitis Severity and Its Association With Visual Acuity
AU - Ballouz, Dena
AU - Niziol, Leslie M.
AU - Prajna, N. Venkatesh
AU - Farsiu, Sina
AU - Shtein, Roni M.
AU - Verkade, Angela
AU - Miller, Keith D.
AU - Sherman, Eric
AU - Pawar, Mercy
AU - Selvaraj, Suvitha
AU - Kuppuraj, Dhanya
AU - Kochar, Prabhleen
AU - Thibodeau, Alexa
AU - Enright, Jennifer
AU - Woodward, Maria A.
N1 - Publisher Copyright:
© 2025 Lippincott Williams and Wilkins. All rights reserved.
PY - 2025/8
Y1 - 2025/8
N2 - Objective: Microbial keratitis (MK) is a vision-threatening and often painful corneal infection. This study aims to quantify severity of symptoms of MK at presentation and investigate their association with visual acuity (VA). Methods: The Automated Quantitative Ulcer Analysis (AQUA) study recruited MK patients from two sites (University of Michigan and Aravind Eye Care System). At presentation, best-corrected VA was recorded. Patients were surveyed on severity of symptoms on a five-point scale for pain or a four-point scale for redness, light sensitivity/glare, and blurry vision. The association between symptom severity and VA was tested with Spearman correlations (r) and Kruskal-Wallis tests. Results: Seven hundred three patients with MK were enrolled in the AQUA study from July 2020 to November 2022. Presenting logMAR VA had a median value of 1.3 (Snellen equivalent, 20/400). Most patients reported pain (98.7%), redness (99.1%), light sensitivity/glare (98.4%), and blurry vision (99.2%). Visual acuity showed a significant correlation with cumulative symptom severity (spearman r¼0.15, P,0.0001). For those who reported pain and blurry vision, VA worsened with increasing symptom severity (P,0.0001). Conclusions: Presenting VA showed a significant positive correlation with cumulative symptom severity and the individual symptoms of pain and blurry vision. Patient-reported symptoms at MK presentation may indicate disease severity.
AB - Objective: Microbial keratitis (MK) is a vision-threatening and often painful corneal infection. This study aims to quantify severity of symptoms of MK at presentation and investigate their association with visual acuity (VA). Methods: The Automated Quantitative Ulcer Analysis (AQUA) study recruited MK patients from two sites (University of Michigan and Aravind Eye Care System). At presentation, best-corrected VA was recorded. Patients were surveyed on severity of symptoms on a five-point scale for pain or a four-point scale for redness, light sensitivity/glare, and blurry vision. The association between symptom severity and VA was tested with Spearman correlations (r) and Kruskal-Wallis tests. Results: Seven hundred three patients with MK were enrolled in the AQUA study from July 2020 to November 2022. Presenting logMAR VA had a median value of 1.3 (Snellen equivalent, 20/400). Most patients reported pain (98.7%), redness (99.1%), light sensitivity/glare (98.4%), and blurry vision (99.2%). Visual acuity showed a significant correlation with cumulative symptom severity (spearman r¼0.15, P,0.0001). For those who reported pain and blurry vision, VA worsened with increasing symptom severity (P,0.0001). Conclusions: Presenting VA showed a significant positive correlation with cumulative symptom severity and the individual symptoms of pain and blurry vision. Patient-reported symptoms at MK presentation may indicate disease severity.
KW - Microbial keratitis—symptoms—Visual acuity
UR - https://www.scopus.com/pages/publications/105009296908
U2 - 10.1097/ICL.0000000000001200
DO - 10.1097/ICL.0000000000001200
M3 - Article
C2 - 40550112
AN - SCOPUS:105009296908
SN - 1542-2321
VL - 51
SP - 336
EP - 342
JO - Eye and Contact Lens
JF - Eye and Contact Lens
IS - 8
ER -